MITOMYCIN
Generic: MITOMYCIN
Sagent PharmaceuticalsManufacturer
INTRAVENOUSRoute
MITOMYCINActive Substance
2021-10-20Original Approval
MITOMYCIN is FDA application ANDA215687, sponsored by GLAND. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
OFF LABEL USE
359 reports
2
DIARRHOEA
150 reports
3
NAUSEA
131 reports
4
THROMBOCYTOPENIA
105 reports
5
NEUTROPENIA
104 reports
6
DRUG INEFFECTIVE
101 reports
7
DISEASE PROGRESSION
98 reports
8
PANCYTOPENIA
93 reports
9
VOMITING
89 reports
10
FATIGUE
78 reports